Endothelin receptors as a potential therapeutic target in the treatment of cardiovascular disease: Rationale for selective antagonism of the ET(A) subtype

被引：0
|
作者：
Webb, ML
Liu, ECK
Aversa, CR
Spinale, FG
Russell, ME
机构：
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT CARDIOVASC BIOCHEM,PRINCETON,NJ 08543
[2] MED UNIV S CAROLINA,DIV CARDIOTHORAC SURG,CHARLESTON,SC 29425
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT MED,SCH MED,BOSTON,MA 02115
来源：
DRUG NEWS & PERSPECTIVES | 1996年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：348 / 350
页数：3
相关论文
共 50 条
  • [41] High-density lipoproteins: A new potential therapeutic target for the prevention of cardiovascular disease
    Brewer, HB
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) : 387 - 391
  • [42] Affinity of the ET(A) selective non-peptide antagonist PD156707 for endothelin receptors in human renal and cardiovascular tissues
    Maguire, JJ
    Kuc, RE
    Doherty, AM
    Davenport, AP
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P35 - P35
  • [43] Advanced glycation end-products as a potential target for treatment of cardiovascular disease
    Silacci, P
    JOURNAL OF HYPERTENSION, 2002, 20 (08) : 1483 - 1485
  • [44] LncRNA ZFAS1 might be a novel therapeutic target in the treatment of cardiovascular disease
    Wang, Mengzan
    Xie, Hong
    Dai, Bo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 337 : 99 - 99
  • [45] Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview
    Parthymos, Ioannis
    Kostapanos, Michael S.
    Mikhailidis, Dimitri P.
    Florentin, Matilda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : 739 - 755
  • [46] Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson's Disease
    Camilo Jurado-Coronel, Juan
    Avila-Rodriguez, Marco
    Capani, Francisco
    Gonzalez, Janneth
    Echeverria Moran, Valentina
    Barreto, George E.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (10) : 1305 - 1311
  • [47] In reply to Schafer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma
    Russignan, Anna
    Spina, Cecilia
    Tamassia, Nicola
    Cassaro, Adriana
    Rigo, Antonella
    Bagnato, Anna
    Rosano, Laura
    Bonalumi, Angela
    Gottardi, Michele
    Zanatta, Lucia
    Giacomazzi, Alice
    Scupoli, Maria T.
    Tinelli, Martina
    Salvadori, Ugo
    Mosna, Federico
    Zamo, Alberto
    Cassatella, Marco A.
    Vinante, Fabrizio
    Tecchio, Cristina
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (06) : 1050 - 1052
  • [48] Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer's Disease
    Frost, Miles
    Keable, Abby
    Baseley, Dan
    Sealy, Amber
    Zbarcea, Diana Andreea
    Gatherer, Maureen
    Yuen, Ho Ming
    Sharp, Matt MacGregor
    Weller, Roy O.
    Attems, Johannes
    Smith, Colin
    Chiarot, Paul R.
    Carare, Roxana O.
    PHARMACEUTICALS, 2020, 13 (09) : 1 - 14
  • [49] Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2
    dos Anjos, Fernanda
    Batista Simoes, Julia Leao
    Assmann, Charles Elias
    Carvalho, Fabiano Barbosa
    Bagatini, Margarete Dulce
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [50] 'Relaxin' the stiffened heart and arteries: The therapeutic potential for relaxin in the treatment of cardiovascular disease
    Samuel, Chrishan S.
    Du, Xiao-Jun
    Bathgate, Ross A. D.
    Summers, Roger J.
    PHARMACOLOGY & THERAPEUTICS, 2006, 112 (02) : 529 - 552
12345